Thursday, February 9, 2012 Last update: 6:33 PM
The Best of U.S. Company Technology News

Eli Lilly and Company

News articles for Eli Lilly and Company:

Thursday, February 9, 2012

Tuesday, February 7, 2012

  • Lilly Recognized as a Top Company for Executive Women
    INDIANAPOLIS, Feb. 7, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has earned a place on the NAFE "Top Companies for Executive Women" list for the fourth consecutive year. The 2012 list, compiled by the National Association for Female Executives (NAFE), recognizes U.S. companies whose policies ... read more

Wednesday, February 1, 2012

Tuesday, January 31, 2012

Tuesday, January 24, 2012

Thursday, January 5, 2012

Friday, December 16, 2011

Wednesday, December 14, 2011

  • Lilly Recognized as One of the Best Places to Work for LGBT Equality
    INDIANAPOLIS, Dec. 14, 2011 /PRNewswire/ -- For the sixth consecutive year, Eli Lilly and Company (NYSE: LLY) has received a 100 percent rating on the Human Rights Campaign (HRC) Corporate Equality Index (CEI) for lesbian, gay, bisexual and transgender (LGBT) equality in the workplace. (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO ) Lilly ... read more

Monday, December 12, 2011

  • Lilly Declares First-Quarter 2012 Dividend
    INDIANAPOLIS, Dec. 12, 2011 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the first quarter of 2012 of $0.49 a share on outstanding common stock. The dividend is payable March 9, 2012 to shareholders of record ... read more
  • Katherine Baicker Elected to Lilly Board of Directors
    INDIANAPOLIS, Dec. 12, 2011 /PRNewswire/ -- Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected Katherine Baicker, Ph.D. as a new member, effective December 12, 2011. Baicker, 40, is Professor of Health Economics in the Department of Health Policy and Management at the Harvard ... read more
  • Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting
    SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced data from an oncology pipeline molecule today at the 53rd Annual Meeting of the American Society of Hematology (ASH). At the meeting, Lilly Oncology presented Phase I data from the investigational therapy LY2784544, ... read more

Friday, December 9, 2011

Thursday, December 8, 2011

Thursday, December 1, 2011

Thursday, November 17, 2011

Wednesday, November 16, 2011

Friday, November 11, 2011

  • F.A.C.E. Diabetes and Anthony Anderson Ask Americans to Rethink Generation D
    INDIANAPOLIS, Nov. 11, 2011 /PRNewswire/ -- For the second year in a row, award-winning actor and comedian Anthony Anderson is teaming up with Eli Lilly and Company's Fearless African-Americans Connected and Empowered (F.A.C.E.) Diabetes initiative to remove the stereotype of Generation D--the belief that type 2 diabetes is an older ... read more

Thursday, November 10, 2011